StockWatch
·

Shanti Gold International Ltd Q2 FY27 Results

SHANTIGOLDQ2 FY27 Results
Filing
Result:Poor· Market: Crashed#Margin squeeze

Outlook: Cautiously Optimistic · Guidance: Cut

MetricValue (₹ Cr)vs Q1 FY27
Revenue745.954.1%
Total Income751.954.7%
Expenditure713.889.4%
PBT38.0741.7%
Net Profit29.5641.4%
OPM5.70%4.27pp
NPM3.93%3.10pp
EPS3.9943.0%
View full financials

Despite 73% revenue growth, adjusted PAT fell 32.5% YoY as OPM collapsed from 14.1% to 5.7% and NPM from 10.1% to 3.9%, signaling a clear deterioration in core profitability for this consumer/retail (gold jewelry) business.

SHANTI GOLD INTERNATIONAL · Q2 FY27 · THE VERDICT

Revenue soars 73% but profit collapses 32% — margin promise unfulfilled

Shanti Gold reported exceptional top-line growth driven by volume expansion and retail formalization, yet profitability plummeted 32.5% year-over-year. Management's own Q2 PAT claims contradict the delivered result—a credibility gap the market is pricing in.

07 Nov 2026 · 6 min read
Q2 Revenue

₹746 Cr

+73.4% YoY vs. ₹430 Cr prior year

Q2 Net profit

₹29.6 Cr

−32.5% YoY vs. ₹43.9 Cr implied

Q2 EBITDA margin

5.7%

Guided 5–7%, prior 7.5–8%

H1 Volume growth

41% YoY

535.5 kg in Q2; +25.4% Q2 YoY

On the surface, Shanti Gold delivered a blowout quarter—₹746 crore in revenue, a 73% leap year-over-year and 102% growth for the half. The story fractures below the line. Net profit fell 32.5% despite the revenue surge, and management has cut EBITDA margin guidance to a 5–7% range from its prior 7.5–8% target. The gap between headline growth and profitability collapse defines the quarter—and raises hard questions about execution and margin recovery.

The claims vs. what holds up

Management's commentary during the call made a series of claims about growth and profitability. Here is what the delivered result and the numbers actually show:

Management's key claims, graded against the delivered result

Q2 PAT growth 13.5% YoY

Delivered result ₹29.6 Cr vs. implied prior-year ₹43.9 Cr = −32.5% YoY

Contradicted (high severity)

H1 PAT growth 32.5% YoY

If Q2 is −32.5% and H1 is +32.5%, Q1 must have +98% growth; not separately disclosed

Contradicted (math inconsistent)

EBITDA growth 15.6% Q2, 29.2% H1

₹42.5 Cr Q2 EBITDA confirmed; growth supported but margin % compressed below guidance

Supported (but margin miss)

Volume up 25.4% YoY Q2, 41% H1

535.5 kg confirmed; growth narrative consistent with retail formalization tailwind

Supported

FY27 revenue guidance ₹3,500 Cr unchanged

Revised to ₹3,200–3,500 Cr range; prior was point estimate ₹3,500 Cr

Overstated (guidance narrowed)

Sustainable EBITDA margin 7.5–8%

Management now guiding 5–7%; explicit cut from prior lower bound of 7.5%

Contradicted

What changed on this call

Shanti Gold stepped back on two material fronts. EBITDA margin guidance was cut to 5–7% from the prior 7.5–8% target. Management frames this as temporary—a product-mix transition and scale-up cost absorption—but it is a concrete downgrade. FY27 revenue was narrowed to a ₹3,200–3,500 crore range from a prior point estimate of ₹3,500 crore, signalling macro caution and the impact of capex delays. Jaipur facility operationalization was pushed back to January–February 2027 from the original November–December timeline. Interior fit-out is ongoing; the 1,200 kg annual capacity addition will now contribute less to H2 FY27 performance. Debt-to-equity was lifted from a 0.5x comfort zone to a target of 1x, expanding leverage to fund growth capex, inventory, and the Dubai office setup. Product mix has expanded to include designer, Turkish, and CZ jewelry lines, a deliberate diversification away from plain gold only—but one carrying near-term margin headwinds.

The bull-bear ledger
  • 73% revenue growth driven by volume expansion and retail formalization tailwind

  • 41% volume growth (H1 YoY) shows strong demand from organized retail partners

  • Marol facility ramp proves capex execution; Jaipur adds 1,200 kg capacity

  • Product diversification (designer, Turkish, CZ) and export growth (6–7% target) credible

  • PAT collapsed 32.5% YoY despite 73% revenue growth—margin pressure acute

  • Management Q2 PAT claim (+13.5% growth) contradicts delivered result (−32.5%)

  • EBITDA margin guidance cut to 5–7% from 7.5–8%; credibility grade C

  • Jaipur facility delayed to Jan–Feb from Nov–Dec; execution risk

  • Inventory buildup (₹13,500/gram) for product launches is a margin headwind

  • Leverage scaling 0.5x to 1x debt-to-equity; refinancing risk if growth falters

Risks, ranked by how much they should concern a holder

Top risks and why they matter

Credibility: PAT narrative vs. delivered result mismatch

High

Management claimed Q2 +13.5% PAT growth; delivered −32.5%. H1 claimed +32.5% conflicts with Q2 detail. Erodes confidence in forward guidance. Analysts will demand reconciliation; stock re-rates on credibility recovery.

Margin recovery timing and path unclear

High

EBITDA margin 5.7% vs. guided 5–7% is compressed. Management frames as 'transitional' but offers no specific recovery timeline. If margins stay at 5–7% beyond 3–4 quarters, the growth story is undermined and multiples compress.

Jaipur facility capex execution delay

Medium

Originally Nov–Dec, now Jan–Feb 2027. Further delays push capacity contribution into Q4 or beyond, missing FY27 margin benefit. Sets a floor on earnings credibility; another miss triggers material re-rating.

Inventory holding cost drag continues

Medium

Inventory at ₹13,500/gram for product launches and ramp. Carrying cost (working capital, gold price volatility) is margin headwind. Slow market absorption of new products deteriorates inventory turns and cash flow.

Leverage 0.5x → 1x without margin recovery proof

Medium

Doubling debt assumes volume growth and margin recovery materialize. If growth stalls or profitability falters, debt servicing tightens. EBITDA ₹42.5 Cr; at 1x leverage, gross debt ~₹40–50 Cr; coverage weakens sharply on profit decline.

Competitive margin pressure from organized retail shift

Medium

Competitor EBITDA ~8%; Shanti 5.7%. The 2.3pp gap may reflect structural channel economics. Persistence of the gap constrains long-term ROE even at higher volumes and limits upside multiple.

How the street is positioned—and what it signals

Price action and valuation: Shanti Gold is trading at ₹272.15, down 37.8% from its all-time high of ₹437.55. The stock is below its 20-day average (₹348.53) and 50-day average (₹304.71), but above its 200-day moving average (₹234.73), suggesting a reset within a longer uptrend. RSI stands at 36.3—neutral territory, not oversold—implying more technical downside is possible if the fundamental story deteriorates. The 52-week range of ₹154.92–₹437.55 shows volatility; current levels are 75% above the low but off the highs.

Institutional positioning: FII ownership has trimmed to 1.92% from 2.18% in Q4 FY26 (−26 basis points), and DII to 1.58% from 2.13% (−55 basis points). A cumulative 81 basis-point decline in institutional holding is a heads-up—institutions are rotating out or scaling back. Promoter ownership remains stable at 74.89%. The FII/DII exits signal the market is repricing Shanti Gold's growth narrative to account for margin pressure and execution risk.

Bulk activity: Recent bulk deals show QE Securities and HRTI Private Limited trading shares near current levels (₹264–266 in early November, ₹341–344 in late October). The trading is institutional rotation—consolidation rather than panic or euphoria. No promoter/insider selling near the all-time high, which is reassuring. Activity is consistent with a market repricing, not accumulation.

Reconciliation: The market's 37.8% drawdown and institutional trim are consistent with the fundamental story. Growth is impressive, but credibility gaps and margin recovery uncertainty are material. The street is saying: Real growth, but prove the profitability story before we add.

What to watch next
  • 1 · Q3 EBITDA margin and Q1 PAT reconciliation

    Management must clarify the Q2 PAT narrative vs. result mismatch. Q3 must show movement toward the 5–7% EBITDA margin range. Any further compression below 5% signals structural headwinds, not temporary costs. Reconciliation of H1 vs. Q2 PAT claims is a credibility requirement.

  • 2 · Jaipur facility operationalization (Jan–Feb 2027)

    On-time operationalization at 1,200 kg annual capacity is critical to margin recovery narrative. Any further delay or ramp issues push recovery into FY28. Watch for utilization rate (target 75–80%) and product-mix contribution (designer, Turkish) from the facility in early reports.

  • 3 · Inventory levels and working capital efficiency

    Inventory at ₹13,500/gram is elevated; watch for reductions in Q3/Q4 as product launches mature and Jaipur ramps. Inventory stagnation into Q4 signals slow market absorption and extended carrying costs. Cash flow deterioration is a yellow flag.

  • 4 · FY27 revenue trajectory vs. ₹3,200–3,500 Cr range

    Volume growth (41% H1, targeting 25–30% near-term) and retail formalization are credible. Watch Q3/Q4 progression toward the range bounds. Veering toward ₹3,000 Cr or below triggers market repricing downward.

Shanti Gold is a company in transition—growth is real, but profitability is the catch. The 73% revenue surge and 41% volume expansion are exceptional, and the retail formalization tailwind is credible. But the 32.5% PAT decline and management's narrative mismatch raise hard questions about execution and cash generation. Margins are under pressure, Jaipur is delayed, and leverage is rising without proof that margin recovery is in hand.

This is a Hold—not a buy until management demonstrates it can scale volumes without margin deterioration, and not a sell because the market and organizational tailwinds are real. The single number to track from here is EBITDA margin (watch for sustained recovery toward 6–7% by Q3/Q4) and Jaipur facility utilization (target 75–80% with product-mix contribution). Credibility will be restored when Q3 earnings and call data confirm or refute the margin recovery narrative. Until then, this is a story of promise—not yet delivered.

Informational and educational content only. Not investment advice.